Enoxaparin Sodium | Sanofi | ||
100, 150 mg/ml;Injectable, Subcuatenous |
More Than $1000 mn
|
||
Less Than 5
|
Less Than 5
|
||
More Than 5
|
None | ||
More Than 5
|
More Than 5
|
||
Indicated for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE): in patients undergoing abdominal surgery who are at risk for thromboembolic complications | |||
Yes
|